Lonza today announced a global commercial partnership with Lipogen for the exclusive rights to sell phosphatidylserine (PS) and PS-based formulations in dietary supplements, medical foods, and food and beverages under the Lonza name. Lonza intends to roll out launch activities in the USA in the fourth quarter of 2011, and expand to other global regions thereafter.
